BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1187 related articles for article (PubMed ID: 15560774)

  • 1. The clinical spectrum of narcolepsy with cataplexy: a reappraisal.
    Sturzenegger C; Bassetti CL
    J Sleep Res; 2004 Dec; 13(4):395-406. PubMed ID: 15560774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
    Nishino S; Kanbayashi T
    Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Narcolepsy with cataplexy].
    Dauvilliers Y; Arnulf I
    Rev Neurol (Paris); 2008; 164(8-9):634-45. PubMed ID: 18805301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Narcolepsy and the hypocretins.
    Wurtman RJ
    Metabolism; 2006 Oct; 55(10 Suppl 2):S36-9. PubMed ID: 16979425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of the diagnostic utility of HLA typing, CSF hypocretin-1 measurements, and MSLT testing for the diagnosis of narcolepsy in 163 Korean patients with unexplained excessive daytime sleepiness.
    Hong SC; Lin L; Jeong JH; Shin YK; Han JH; Lee JH; Lee SP; Zhang J; Einen M; Mignot E
    Sleep; 2006 Nov; 29(11):1429-38. PubMed ID: 17162989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A).
    Bassetti C; Gugger M; Bischof M; Mathis J; Sturzenegger C; Werth E; Radanov B; Ripley B; Nishino S; Mignot E
    Sleep Med; 2003 Jan; 4(1):7-12. PubMed ID: 14592354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Narcolepsy].
    Billiard M; Cadilhac J
    Rev Neurol (Paris); 1985; 141(8-9):515-27. PubMed ID: 2868518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients.
    Mignot E; Hayduk R; Black J; Grumet FC; Guilleminault C
    Sleep; 1997 Nov; 20(11):1012-20. PubMed ID: 9456467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical, behavioural and polysomnographic correlates of cataplexy in patients with narcolepsy/cataplexy.
    Mattarozzi K; Bellucci C; Campi C; Cipolli C; Ferri R; Franceschini C; Mazzetti M; Russo PM; Vandi S; Vignatelli L; Plazzi G
    Sleep Med; 2008 May; 9(4):425-33. PubMed ID: 17681883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias.
    Mignot E; Lammers GJ; Ripley B; Okun M; Nevsimalova S; Overeem S; Vankova J; Black J; Harsh J; Bassetti C; Schrader H; Nishino S
    Arch Neurol; 2002 Oct; 59(10):1553-62. PubMed ID: 12374492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypocretin deficiency in narcolepsy with cataplexy is associated with a normal body core temperature modulation.
    Grimaldi D; Agati P; Pierangeli G; Franceschini C; Guaraldi P; Barletta G; Vandi S; Cevoli S; Plazzi G; Montagna P; Cortelli P
    Chronobiol Int; 2010 Sep; 27(8):1596-608. PubMed ID: 20854137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obstructive sleep apnea in narcolepsy.
    Sansa G; Iranzo A; Santamaria J
    Sleep Med; 2010 Jan; 11(1):93-5. PubMed ID: 19699146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The reliability of the diagnostic features in patients with narcolepsy.
    Folkerts M; Rosenthal L; Roehrs T; Krstevska S; Murlidhar A; Zorick F; Wittig R; Roth T
    Biol Psychiatry; 1996 Aug; 40(3):208-14. PubMed ID: 8830954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features of childhood narcolepsy. Can cataplexy be foretold?
    Nevsimalova S; Jara C; Prihodova I; Kemlink D; Sonka K; Skibova J
    Eur J Paediatr Neurol; 2011 Jul; 15(4):320-5. PubMed ID: 21345702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlates of sleep-onset REM periods during the Multiple Sleep Latency Test in community adults.
    Mignot E; Lin L; Finn L; Lopes C; Pluff K; Sundstrom ML; Young T
    Brain; 2006 Jun; 129(Pt 6):1609-23. PubMed ID: 16597649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of the multiple sleep latency test (MSLT) for the diagnosis of narcolepsy.
    Aldrich MS; Chervin RD; Malow BA
    Sleep; 1997 Aug; 20(8):620-9. PubMed ID: 9351129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of humoral immunity to preprohypocretin in human leukocyte antigen DQB1*0602-positive narcoleptic subjects with cataplexy.
    Black JL; Silber MH; Krahn LE; Avula RK; Walker DL; Pankratz VS; Fredrickson PA; Slocumb NL
    Biol Psychiatry; 2005 Sep; 58(6):504-9. PubMed ID: 16043129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between clinical characteristics of narcolepsy and CSF orexin-A levels.
    Nakamura M; Kanbayashi T; Sugiura T; Inoue Y
    J Sleep Res; 2011 Mar; 20(1 Pt 1):45-9. PubMed ID: 20642748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Childhood onset of narcolepsy-cataplexy syndrome in Turkey: clinical and genetic study.
    Pelin Z; Bozluolcay M; Kaynak D; Kaynak H
    Turk J Pediatr; 2002; 44(4):321-5. PubMed ID: 12458808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid eye movement sleep behaviour disorder in patients with narcolepsy is associated with hypocretin-1 deficiency.
    Knudsen S; Gammeltoft S; Jennum PJ
    Brain; 2010 Feb; 133(Pt 2):568-79. PubMed ID: 20129934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.